Skip to content
healthcare.dev

Omeprazole

NDC 41250-349, omeprazole, tablet, orally disintegrating, delayed release, from Meijer Distribution Inc.

Product NDC
41250-349
Status
Listed
Labeler
Meijer Distribution Inc
Dosage form
TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
NDA
Application
NDA209400
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/41250-349 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OMEPRAZOLE20 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]

Package NDCNDC-11Package
41250-349-55412500349553 CARTON in 1 CARTON (41250-349-55) / 14 BLISTER PACK in 1 CARTON / 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 41250-349 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/41250-349 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 41250-349. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.